
Biomolecules, Год журнала: 2024, Номер 14(7), С. 862 - 862
Опубликована: Июль 19, 2024
Glucose and lipid metabolism are essential energy sources for the body. Dysregulation in these metabolic pathways is a significant risk factor numerous acute chronic diseases, including type 2 diabetes (T2DM), Alzheimer’s disease (AD), obesity, cancer. Post-translational modifications (PTMs), which regulate protein structure, localization, function, activity, play crucial role managing cellular glucose metabolism. Among PTMs, lysine methylation stands out as key dynamic modification vital epigenetic regulation of gene transcription. Emerging evidence indicates that significantly impacts by modifying enzymes proteins. This review summarizes current understanding methylation’s regulatory mechanisms We highlight involvement methyltransferases (KMTs) demethylases (KDMs) generating abnormal signals affecting pathways. Additionally, we discuss chemical biology pharmacology KMT KDM inhibitors targeted degraders, emphasizing their clinical implications diseases such diabetes, neurodegenerative disorders, cancers. suggests targeting could be an ideal therapeutic strategy treating diseases.
Язык: Английский